CICC Research Begins Coverage on Intuitive Surgical (NASDAQ:ISRG)

Equities researchers at CICC Research began coverage on shares of Intuitive Surgical (NASDAQ:ISRG) in a research report issued on Monday. The firm set a “neutral” rating and a $550.00 price target on the medical equipment provider’s stock. CICC Research’s target price suggests a potential downside of 4.29% from the stock’s previous close.

Other analysts have also issued research reports about the stock. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research note on Friday. Raymond James lifted their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a research report on Friday, October 18th. Royal Bank of Canada upped their target price on Intuitive Surgical from $611.00 to $641.00 in a report on Monday. Finally, Mizuho upped their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and an average target price of $610.95.

Intuitive Surgical Trading Down 1.6 %

Shares of ISRG traded down $9.41 during trading hours on Monday, reaching $574.65. 1,391,095 shares of the company traded hands, compared to its average volume of 1,954,819. Intuitive Surgical has a 12-month low of $364.17 and a 12-month high of $616.00. The stock’s fifty day moving average price is $547.16 and its 200 day moving average price is $505.21. The firm has a market cap of $204.68 billion, a price-to-earnings ratio of 92.27, a PEG ratio of 5.19 and a beta of 1.39.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the business’s stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 42,453 shares of company stock valued at $22,059,506. Corporate insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Hedge funds and other institutional investors have recently bought and sold shares of the company. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. Godsey & Gibb Inc. lifted its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical in the third quarter valued at $38,000. 83.64% of the stock is owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.